Variables | |
---|---|
Sex (man / woman) | 364 / 221 |
Age, medial, range (y) | 69 (34–92) |
Comorbidity | 333 (56.9%) |
Malignant disease | 81 (13.8%) |
Hypertension | 92 (15.7%) |
Diabetes mellitus | 81 (13.8%) |
Angina pectoris | 37 (6.3%) |
COPD | 35 (5.9%) |
Cerebral infarction | 24 (4.1%) |
Arrhythmia | 20 (3.4%) |
Interstitial lung disease | 9 (1.5%) |
Asthma | 20 (3.4%) |
Autoimmune disease | 15 (2.5%) |
Chronic renal failure | 7 (1.1%) |
Body mass index, median (range) | 22.8 (14.3–36.6) |
CEA, median, range (ng/ml) | 3.4 (0.5–306) |
Brinkman index, median (range) | 600 (0–3600) |
PNI, median (range) | 50.0 (26.9–67.5) |
NLR, median (range) | 2.14 (0.66–12.65) |
%VC, median (range) | 111 (45.7–184.2) |
FEV1%, median (range) | 73.4 (30.5–99.5) |
Lobe of lung cancer (RU / RM / RL / LU / LL) | 179 / 37 / 137 / 139 / 93 |
pStage (0 / IA / IB / IIA / IIB / IIIA / IIIB / IV / yIA / yIIA) | 32 / 284 / 107 / 43 / 57 / 51 / 3 / 2 / 5 / 1 |
Histological type (Ad / Sq / LCNEC / AdSq / Pleo / Large / Carci) | 441 / 108 / 17 / 9 / 4 / 3 / 3 |
Operative approach (Open / VATS / RATS) | 71 / 662 / 6 |
Location of Lobectomy (RU / RM / RL / LU / LL) | 175 / 36 / 106 / 108 / 76 |
Operative procedure (Seg / Lob / Lob + CW / Lob + Seg / Sleeve Lob / Bilob / Pneumo) | 68 / 473 / 9 / 3 / 4 / 10 / 18 |
Morbidity | 176 (30.0%) |
Air leakage | 81 (13.8%) |
Arrhythmia | 44 (7.5%) |
Atelectasis | 19 (3.2%) |
Pneumonia | 12 (2.0%) |
Attack of asthma | 4 (0.6%) |
Cerebral infarction | 3 (0.5%) |
Chylothorax | 2 (0.3%) |
Broncho-pleural fistula | 2 (0.3%) |
Clavien–Dindo grade (0 / I / II / IIIa / IIIb) | 409 / 1 / 71 / 99 / 5 |
Mortality | 1 (0.1%) |
Mortality or severe morbidity | 67 (11.4%) |
Tracheal or bronchial fistula | 2 (0.3%) |
Respiratory disfunction | 4 (0.6%) |
NCD risk score | |
Mortality, median (range) (%) | 0.2 (0–10.6) |
Mortality or severe morbidity, median (range) (%) | 4.6 (1–39.3) |
Tracheal or bronchial fistula, median (range) (%) | 0.2 (0–8.1) |
Respiratory disfunction, median (range) (%) | 0.2 (0–8.2) |